Asian Spectator


The Times

.

Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform

  • Written by PR Newswire Asia - Asian Spectator
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform

MELBOURNE, Australia , Feb. 8, 2024 /PRNewswire/ --.Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM is a United States (U.S.) based company developing...

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink StreamEastzlibraryzlibraryzlibrarybetpipo girisgalabetCrackStreams1xbetfixbet girişjojobetholiganbetcasibomcasibomPadişahbethitbet girisVipparkjojobettaraftarium24vipparktaraftariumjojobethacklink panelCrackStreamsyks koçlukuk casinos not on gamstop